Table 1

Bivariate logistic univariate regression of the factors for patients with DTC with hepatic dysfunction

Relevant factorsWith hepatic dysfunction (n (%))Without hepatic dysfunction (n (%))BOR value95% CIP value
Age≤45
>45
350 (68.50)
331 (68.25)
161 (31.50)
154 (31.75)
−1.0111
1.011
0.744 to 1.3210.934
SexMale
Female
158 (50.97)
523 (76.24)
152 (49.03)
163 (23.76)
−1.1271
0.324
0.244 to 0.4300.000
Time between thyroidectomy and 131I therapy≤3 months
>3 months
560 (68.20)
121 (69.14)
261 (31.80)
54 (30.86)
0.0431
1.044
0.734 to 1.4860.810
Thyroid hormone withdrawal time≤21 days
>21 days
372 (72.51)
309 (63.98)
141 (27.49)
174 (36.02)
0.3961
1.486
0.517 to 0.8920.005
MetastasesNegative
Positive
152 (72.38)
529 (67.30)
58 (27.62)
257 (32.70)
−0.2421
0.785
0.561 to 1.1000.160
Hashimoto’s thyroiditisNegative
Positive
595 (67.85)
86 (72.27)
282 (32.15)
33 (27.73)
−0.2111
0.810
0.529 to 1.2390.331
FT3<2.01*
≥2.01
316 (63.71)
365 (73.00)
180 (36.29)
135 (27.00)
0.4321
1.540
1.177 to 2.0160.002
FT4<4.78*
≥4.78
280 (56.34)
401 (80.36)
217 (43.66)
98 (19.64)
1.1541
3.171
2.389 to 4.2090.000
TSH<78.195*
≥78.195
365 (73.29)
316 (63.45)
133 (26.71)
182 (36.55)
−0.4581
0.633
0.483 to 0.8280.001
Tg<2.635*
≥2.635
346 (69.48)
335 (67.27)
152 (30.52)
163 (32.73)
−0.1851
0.831
0.609 to 1.1340.244
TgAb≤40†
>40
527 (66.96)
154 (73.68)
260 (33.04)
55 (26.32)
0.3811
1.374
0.979 to 1.9300.067
TC≤5.17†
>5.17
129 (75.44)
552 (66.90)
42 (24.56)
273 (33.10)
0.7581
2.135
1.615 to 2.8220.000
TG≤1.71†
>1.71
336 (77.42)
344 (61.54)
98 (22.58)
215 (38.46)
−0.4181
0.658
0.451 to 0.9600.03
  • *Median.

  • †Upper limit of the normal value.

  • DTC, differentiated thyroid cancer; FT3, free triiodothyronine; FT4, free thyroxine; TC, total cholesterol; Tg, thyroglobulin; TG, triglycerides; TgAb, antithyroglobulin antibody; TSH, thyroid-stimulating hormone.